When and how much fluid to remove in critically ill patients
Official title: Timing and Dose of Fluid Deresuscitation in Critically Ill Patients: a Prospective Observational Multicenter Study
Run by Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) · NCT07275658 · Data updated 2026-11-12
This study will test which patients, timing, and rates of fluid removal (diuretics or ultrafiltration) work best for critically ill adults in the ICU who need deresuscitation.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 150 (estimated) |
| Sponsor | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) Academic / other |
| Locations | 2 sites (Amsterdam and 1 other locations) |
| Status | Recruiting |
| Started | October 15, 2025 |
| Main results expected | January 31, 2027 |
| Study ends | February 28, 2027 |
| Registry record updated | January 21, 2026 |
| Trial ID | NCT07275658 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adult ICU patients at a participating site who have a first clinical indication for deresuscitation using diuretics or ultrafiltration as decided by the treating physician are ideal candidates.
✕Probably not a fit
Patients under 18, those with major cardiac shunts or moderate-to-severe aortic regurgitation, morbid obesity (BMI >40), pre-existing lung disease preventing reliable ultrasound, those on ECMO or transferred from another ICU, moribund patients, or those who opt out are unlikely to benefit from participation.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a multicenter, prospective observational cohort of adult ICU patients who have a treating-physician–determined indication for deresuscitation. Clinical data, point-of-care ultrasound measures, and laboratory and metabolic profiles will be collected during the first attempt at deresuscitation. The primary outcome is successful deresuscitation, defined as achieving a negative fluid balance within 24 hours without hemodynamic consequences, with secondary work on timing, rate (dose) and subgroup differences (sepsis, ARDS, cardiac patients). Analyses will explore predictors of diuretic and ultrafiltration response, optimal individualized deresuscitation rates, and associations with complications such as electrolyte/acid–base disturbances, hemodynamic instability, atrial fibrillation, and delirium.
Why it matters
Potential benefit: If successful, the findings could help clinicians personalize when and how fast to remove fluid to make deresuscitation safer and more effective, potentially reducing complications.
How similar studies have gone: Previous research supports conservative fluid management and diuresis in critical illness, but prospectively defining determinants and individualizing timing and dose using integrated ultrasound and metabolic profiling is relatively novel and not yet proven.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Admission to one of the participating ICUs; * Clinical indication for deresuscitation using diuretics or ultrafiltration as set by the treating physician; first attempt during the ICU stay. Exclusion Criteria: * Age below 18 years old; * Major cardiac shunts; * Moderate to severe aortic regurgitation; * Morbid Obesisty (BMI \>40); * POCUS impossible or unreliable (i.e. pre-existing interstitial lung disease); * PLR or modified form of PLR impossible (i.e. ECMO); * Transfer from another ICU; * Previous inclusion in this study; * Patients who are moribund or facing the end of life; * Opt out.
Where it's running
-
Olvg
Amsterdam, Netherlands Recruiting -
Amsterdam UMC
Amsterdam, Netherlands Recruiting
Study contacts
- Study coordinator: Krijna Opschoor, MD
- Email: k.opschoor@amsterdamumc.nl
- Phone: +31 (0)20 566 9111
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Using a bioimpedance device to track fluid status in children after stem cell transplant
The study tests whether bedside bioimpedance measurements can reliably track body water changes in children undergoing stem cell transplantation, alongside standard fluid checks.
-
Personalized High-Rate Fluid Removal Guided by Ultrasound in Hospitalized ESRD with Fluid Overload
This trial tests whether using ultrasound to guide a higher rate of fluid removal is as safe and effective as standard fluid removal for adults with end-stage kidney disease who are admitted for severe fluid overload.
-
Understanding how patients tolerate fluid removal during kidney support in the ICU
This observational study tests how well critically ill adults with acute kidney injury tolerate net fluid removal during continuous renal replacement therapy.
-
Electric cardiometry-guided fluid therapy during robotic prostatectomy
This study tests whether using an electrical cardiometry device to guide fluid administration during robotic prostatectomy improves patient care compared with a standard fluid approach.
-
Deciphering why some patients stay a long time in the ICU using detailed clinical profiling
This study will try to identify clinical patterns in adults who stay in the ICU five days or longer to better understand persistent critical illness.
-
Delphi consensus to guide mechanical insufflation-exsufflation use in the ICU
A panel of ICU and lung specialists will use a structured survey process to agree on best practices for using mechanical insufflation-exsufflation to help airway clearance in critically ill patients.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.